Terms: = Pancreatic cancer AND EPS15, AF-1P, 2060, ENSG00000085832, P42566, MLLT5, AF1P AND Treatment
5 results:
1. Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options.
Zhang CY; Liu S; Yang M
World J Gastroenterol; 2022 Dec; 28(48):6827-6845. PubMed ID: 36632312
[TBL] [Abstract] [Full Text] [Related]
2. [Stereotactic ablative body radiotherapy (SABRT) for locally advanced pancreatic cancer. Case report and review of literature].
Földi G; Zongor Z; Polgár C; Stelczer G; Madaras B; Andi J; Lövey J
Magy Onkol; 2017 Dec; 61(4):387-392. PubMed ID: 29257159
[TBL] [Abstract] [Full Text] [Related]
3. Irinotecan plus cisplatin followed by octreotide long-acting release maintenance treatment in advanced gastroenteropancreatic neuroendocrine carcinoma: IPO-NEC study.
Li J; Lu M; Lu Z; Li Z; Liu Y; Yang L; Li J; Zhang X; Zhou J; Wang X; Gong J; Gao J; Li Y; Shen L
Oncotarget; 2017 Apr; 8(15):25669-25678. PubMed ID: 27788498
[TBL] [Abstract] [Full Text] [Related]
4. [Safety and tolerability of GLP-1 receptor agonists].
Soldevila B; Puig-Domingo M
Med Clin (Barc); 2014; 143 Suppl 2():35-40. PubMed ID: 25326842
[TBL] [Abstract] [Full Text] [Related]
5. [Endocrine tumors of the pancreas (EPTs) in multiple endocrine neoplasia (MEN1): up-date on prognostic factors, diagnostic procedures and treatment].
Libé R; Chanson P
Ann Endocrinol (Paris); 2007 Jun; 68 Suppl 1():1-8. PubMed ID: 17961653
[TBL] [Abstract] [Full Text] [Related]
